This study emphasizes on the effect of telemonitoring and the effect on compliance in the first period after starting the treatment.
ID
Source
Brief title
Condition
- Other condition
- Respiratory disorders NEC
Synonym
Health condition
slaapgeneeskunde/OSAS
Research involving
Sponsors and support
Intervention
Outcome measures
Primary outcome
mean hours/night CPAP use after 10 weeks, compared between the two groups.
Secondary outcome
a. Number of patients who stop their therapie after 10 weeks and after 1 year
b. Increased efficiency of treatment, regarding check-up's and hospital visits
c. CPAP related complaints/symptoms
Background summary
Obstructive sleep apnea (OSA) is the most common sleep-related breathing
disorder.
Continuous positive airway pressure is the treatment of choice, with adherence
of 60-70%.
Because short-term adherence and early perceived benefits are the best
predictors of long-term adherence, efforts to optimise adherence are best done
before or shortly after starting treatment. Intensive support can be beneficial
according to some studies.
Telemonitoring is enabling clinicians and patients to continuously obtain
specific parameters
of disease processes, thereby permitting prompt and timely adjustments to
therapy if
needed. Regarding telemonitoring in patients with OSAS, there have been several
studies, but not yet
in OSAS patients in the Netherlands. Studies of Sparrow et al and Fox et al
showed that an
intervention (by telemonitoring) resulted in improved CPAP adherence. Of course
there are
several limitations within these studies and there is need for more research.
This study emphasizes on the effect of telemonitoring and the effect on
compliance in the first period after starting the treatment in the dutch
population. Adoption of this type of system could result in substantially
improved care of patients with OSAS.
Study objective
This study emphasizes on the effect of telemonitoring and the effect on
compliance in the first period after starting the treatment.
Study design
Randomized Controlled trial, single blind.
250 patients
Intervention
Telemonitoring of the CPAP machine
Study burden and risks
none
Molengracht 21 Molengracht 21
Breda 4818 CK
NL
Molengracht 21 Molengracht 21
Breda 4818 CK
NL
Listed location countries
Age
Inclusion criteria
- newly diagnosed OSAS patient
- apnea hypopnea index > 29/hour
- CPAP therapy
- Age between 18-75 years
Exclusion criteria
- anxiety disorder
- mental disorder/retardation
- significant central sleep apnea component
- expected other changes in physical well being cause of comorbidity/other diseases and expected weight loss or gain such as pregnancy, bariatric surgery.
Design
Recruitment
Followed up by the following (possibly more current) registration
No registrations found.
Other (possibly less up-to-date) registrations in this register
No registrations found.
In other registers
| Register | ID |
|---|---|
| CCMO | NL52339.015.15 |